Loading the company…
Loading the company…
Families: Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Happe Spine (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2023 (1). The latest was on 2023-04-28.
| Family | Decisions on record |
|---|---|
| Cervical fusion & disc arthroplasty | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-04-28 | 510(k) | K222004 | INTEGRATE -C Interbody Fusion System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Happe Spine.
In 2025, Happe Spine reported engagement with 6 surgeons and other clinicians in the states MedaRep covers, worth $9,588 in consulting, speaking, meals and travel for its device products, the most in Indiana ($8,702 to 2). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Indiana ($8,702, 2 engaged), California ($526, 2 engaged), Illinois ($182, 1 engaged), Maryland ($177, 1 engaged).